2 completed, 2 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Unknown 2 |
| Phase 1 | 1 | Completed 1 |
Follow Kitasato University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in COvid-19 Patients With iveRmectin (CORVETTE-01) Ivermectin 3 MG, Placebo - Covid19 | Phase 2 | Unknown | Kitasato University | 214 | 2020-09-16 | 2022-01-20 |
| First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation M201-A Injection, Placebo - Paroxysmal Atrial Fibrillation | Phase 2 | Unknown | Kitasato University | 42 | 2019-05-07 | 2020-10-30 |
| iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study Bosutinib (Phase 1 part), Bosutinib (Phase 2 part) - Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Completed | Kyoto University | 46 | 2019-03-19 | 2026-08-10 |
| Clinical Trial of Chemosensitivity Test S-1 - Gastric Cancer | Phase 2 | Completed | Japan Clinical Cancer Research Organization | 300 | 2006-03-01 | 2011-06-29 |
Amyotrophic Lateral Sclerosis (1) · Atrial Fibrillation (1) · COVID-19 (1) · Stomach Neoplasms (1)
Ivermectin (1) · S 1 (combination) (1) · bosutinib (1)
Japan (4)
Haruhisa Inoue (1) · Kunihiro K.Y Yamaoka, Ph.D (1) · Tetsuro Kubota, Processor (1)